Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples